Clinical trial

Effect of EGb761® on Brain Glucose Metabolism in Three Groups of Elderly Defined by Cognitive Functions

NCT00814346

Study summary

ClinicalTrials.gov

Effect of EGb761® on Brain Glucose Metabolism in Three Groups of Elderly Defined by Cognitive Functions

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention EGb761® Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-10-01

PhasePHASE2

Conditions

Alzheimer's Diseaseverified · MONDO: Alzheimer disease

Cognitive Impairmentunresolved

Interventions

EGb761®DRUG

PlaceboDRUG

Sponsors & collaborators

Ipsenlead sponsor

Mapped research locations

ParisFrance3 VillejuifFrance1 Issy-les-MoulineauxFrance1 OrsayFrance1 Juvisy-sur-OrgeFrance1 Le VésinetFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00814346 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.